Female sexual satisfaction and pharmaceutical intervention: A critical review of the drug intervention studies in female sexual dysfunction

被引:31
|
作者
Nijland, Esme
Davis, Susan
Laan, Ellen
Schultz, Willibrord Weijmar
机构
[1] NV Organon, Med Serv Womens Hlth, Urol, NL-5340 BH Oss, Netherlands
[2] Monash Univ, Alfred Hosp, Womens Hlth Program, Clayton, Vic 3168, Australia
[3] Univ Amsterdam, Acad Med Ctr, Dept Sexol & Psychosomat Obstet Gynecol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Groningen Hosp, Dept Gynecol, Groningen, Netherlands
来源
JOURNAL OF SEXUAL MEDICINE | 2006年 / 3卷 / 05期
关键词
female sexual dysfunction; menopause; hormones; estrogens; testosterone; sildenafil; DHEAS; androgens;
D O I
10.1111/j.1743-6109.2006.00285.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. A considerable number of double-blind randomized controlled studies investigating the effects of pharmaceutical intervention on female sexual functioning have been published in recent years. However, a comparison between outcomes of various studies is difficult as no generally accepted/correct approach to research has been established yet. To be able to translate trial results to daily clinical practice, current limitations and issues in drug intervention studies in female sexual dysfunction (FSD) need to be clarified. Aim. To evaluate the needs in research into intervention in FSD by reviewing published studies. Methods. A systematic review of double-blind randomized controlled intervention trials on FSD. Main Outcome Measures. Definitions of study populations, inclusion and exclusion criteria, use of power calculations, outcome measures and treatment duration. Results. A total of 25 double-blind randomized controlled trials investigating the effects of pharmaceutical intervention on female sexual functioning have been published. Of these, 11 studies required the diagnosis of FSD as an inclusion criterion. A standard methodology for research in this field is lacking. Significant differences in population inclusion requirements and tools for the measurement of change in sexual functioning were identified as major limiting factors. Conclusions. The investigation of FSD is an evolving area in that new definitions and a new model for female sexual functioning have been recently proposed. There is a need for experts in the field and regulating authorities to reach a consensus regarding appropriate inclusion and exclusion criteria for FSD trials and main outcome measures appropriate for the evaluation of drug interventions. This consensus should also determine which treatment effect is considered to be clinically relevant. Treatment efficacy and clinical relevance should be related to outcomes which are meaningful for affected women.
引用
收藏
页码:763 / 777
页数:15
相关论文
共 50 条
  • [31] Female sexual dysfunction
    Kershaw, Victoria
    Jha, Swati
    OBSTETRICIAN & GYNAECOLOGIST, 2022, 24 (01): : 12 - 23
  • [32] Female Sexual Dysfunction
    Clayton, Anita H.
    Hamilton, David V.
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2010, 33 (02) : 323 - +
  • [33] Female sexual dysfunction
    Freedman, MA
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 2002, 47 (01): : 18 - 21
  • [34] Female sexual dysfunction
    David Fitzhenry
    Leslie Sandberg
    Nature Reviews Drug Discovery, 2005, 4 : 99 - 100
  • [35] Female sexual dysfunction
    Lightner, DJ
    MAYO CLINIC PROCEEDINGS, 2002, 77 (07) : 698 - 702
  • [36] Female sexual dysfunction
    Aslan, Erdogan
    Fynes, Michelle
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2008, 19 (02) : 293 - 305
  • [37] Sexual Function Measures in Intervention Studies with Female Cancer Patients: Results from a Systematic Review
    Reese, Jennifer
    Jeffery, Diana
    Barbera, Lisa
    Andersen, Barbara
    Siston, Amy
    Jhingran, Anuja
    Shirley, Baron
    Coady, Deborah
    Carter, Jeanne
    Flynn, Kathryn
    PSYCHO-ONCOLOGY, 2015, 24 : 263 - 263
  • [38] Female Sexual Dysfunction
    Wright, Jennifer J.
    O'Connor, Kim M.
    MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (03) : 607 - +
  • [39] PHYSIOTHERAPY IN FEMALE SEXUAL DYSFUNCTION: A REVIEW OF LITERATURE
    da Silva Leite, Amanda Maria
    Cabral de Sousa Lafayette, Gabriela Maria
    Alvares Barbosa, Leila Maria
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 392 - 392
  • [40] The Genetics and Epidemiology of Female Sexual Dysfunction: A Review
    Burri, Andrea V.
    Cherkas, Lynn M.
    Spector, Tim D.
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 (03): : 646 - 657